14-3-3 gamma antibody (N-Term)
Quick Overview for 14-3-3 gamma antibody (N-Term) (ABIN2779360)
Target
See all 14-3-3 gamma (YWHAG1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Sequence
- EERNLLSVAY KNVVGARRSS WRVISSIEQK TSADGNEKKI EMVRAYREKI
-
Predicted Reactivity
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 100%
-
Characteristics
- This is a rabbit polyclonal antibody against Ywhag. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 247 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- 14-3-3 gamma (YWHAG1)
-
Alternative Name
- Ywhag
-
Background
-
Ywhag is an adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Ywhag binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Ywhag binding generally results in the modulation of the activity of the binding partner.
Alias Symbols: 14-3-3gamma, D7Bwg1348e
Protein Interaction Partner: Mapt, Kcnma1, Mdm4, Eed, CALM1, Fbxo32, Rara, Rpgrip1l, Ywhaz, Mark3, Mark2, Nedd4l, Htt, Lrrk2, Crk, Ywhae, Lmna, SNCA,
Protein Size: 247 -
Molecular Weight
- 28 kDa
-
Gene ID
- 22628
-
NCBI Accession
- NM_018871, NP_061359
-
UniProt
- P61982
-
Pathways
- Myometrial Relaxation and Contraction, M Phase
Target
-